Mesa Laboratories, Inc.
MLAB
$125.73
$3.402.78%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 8.66% | -0.58% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 8.66% | -0.58% | |||
| Cost of Revenue | 5.30% | 8.84% | |||
| Gross Profit | 10.71% | -5.57% | |||
| SG&A Expenses | 5.89% | 1.41% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.92% | 3.97% | |||
| Operating Income | 45.86% | -37.68% | |||
| Income Before Tax | -158.16% | -2.38% | |||
| Income Tax Expenses | -240.89% | -25.73% | |||
| Earnings from Continuing Operations | -148.89% | 1.18% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -148.89% | 1.18% | |||
| EBIT | 45.86% | -37.68% | |||
| EBITDA | 12.42% | -15.17% | |||
| EPS Basic | -148.74% | 0.88% | |||
| Normalized Basic EPS | -151.81% | 186.23% | |||
| EPS Diluted | -149.21% | 1.61% | |||
| Normalized Diluted EPS | -152.37% | 184.64% | |||
| Average Basic Shares Outstanding | 0.30% | 0.30% | |||
| Average Diluted Shares Outstanding | -0.77% | 0.87% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -3.05% | -0.01% | |||
